@misc{indiciae54b91d26e999,
  title = {A novel HER2-targeted antibody-drug conjugate offers the possibility of clinical dosing at trastuzumab-equivalent exposure levels},
  author = {Barfield, R. M. and Kim, Y. C. and Chuprakov, S. and Zhang, F. and Bauzon, M. and Ogunkoya, A. O. and Yeo, D. and Hickle, C. and Pegram, M. D. and Rabuka, D. and Drake, P. M.},
  year = {2020},
  doi = {10.1101/2020.03.13.991448},
  url = {https://www.biorxiv.org/content/10.1101/2020.03.13.991448v1},
  note = {Source identifier: 10.1101/2020.03.13.991448}
}